FdaApplication
NDA 211215
Identifiers
- fda_app_no: NDA211215
Properties
| Property | Value |
|---|---|
| applicant_name | MAIA PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2019-07-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANGIOMAX RTU | BIVALIRUDIN | 250MG/50ML (5MG/ML) | SOLUTION;INTRAVENOUS |
1 product